The Economist @TheEconomist
“About 50% of people get enough of a benefit that they think it’s worth coming back for more.” Rupert McShane, who runs a ketamine clinic @OxPsychiatry, weighs up the efficacy of the therapy for people with treatment-resistant depression, on “Babbage” https://t.co/RuBoXYWrja — PolitiTweet.org